全文获取类型
收费全文 | 116篇 |
免费 | 10篇 |
专业分类
126篇 |
出版年
2021年 | 1篇 |
2019年 | 1篇 |
2018年 | 1篇 |
2017年 | 1篇 |
2016年 | 4篇 |
2015年 | 7篇 |
2014年 | 11篇 |
2013年 | 13篇 |
2012年 | 10篇 |
2011年 | 5篇 |
2010年 | 7篇 |
2009年 | 3篇 |
2008年 | 6篇 |
2007年 | 3篇 |
2006年 | 6篇 |
2005年 | 2篇 |
2004年 | 2篇 |
2003年 | 2篇 |
2002年 | 2篇 |
2000年 | 2篇 |
1999年 | 2篇 |
1998年 | 5篇 |
1997年 | 3篇 |
1996年 | 3篇 |
1993年 | 2篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1980年 | 2篇 |
1978年 | 1篇 |
1973年 | 2篇 |
排序方式: 共有126条查询结果,搜索用时 15 毫秒
121.
The metabolism of 2-fluoro-2-deoxy-D-glucose (FDG) in vivo was observed noninvasively in rat brain using 19F nuclear magnetic resonance (NMR) spectroscopy following an intravenous injection of FDG (400 mg/kg). At 3 h after infusion, four resonances with discrete chemical shifts were resolved. Chemical shift analysis of these resonances suggested the chemical identity of two of the resonances to be FDG and/or FDG-6-phosphate and 2-fluoro-2-deoxy-delta-phosphogluconolactone and/or 2-fluoro-2-deoxy-6-phosphogluconate. The chemical identities of the other two resonances remain to be elucidated. The present study indicates that the metabolism of FDG in vivo is more extensive than is previously recognized and demonstrates the feasibility of using 19F NMR spectroscopy to follow the 19F-containing metabolites of FDG in vivo. 相似文献
122.
Replacement of receptor cells in the hamster vomeronasal epithelium after nerve transection 总被引:1,自引:1,他引:0
Chemoreceptor cells in the vomeronasal and olfactory epithelium are
replaced following experimentally induced degeneration. This study analyzes
quantitatively the time course and degree of vomeronasal receptor cell
replacement. Unilateral transection of the vomeronasal nerves in adult
hamster was used to induce a retrograde degeneration of receptor cells in
the vomeronasal organ. Histological measurement of both number of receptor
cells and epithelial thickness were made for recovery times from 0 to 60
days. After nerve transection, there was a gradual degeneration of receptor
cells, the number decreasing to 50% of control by day 2 and 16% by day 6.
During days 7-15 maximum receptor cell replacement was observed. Cell
number increased rapidly and reached a peak on day 15. At recovery times of
40-60 days, cell number returned to the control level. Epithelial
thickness, however, decreased to 60-70% during the degeneration period
(days 4-6) and did not return to control levels. After 40-60 days
epithelial thickness remained at 70% of control. These results demonstrate
that vomeronasal receptor cells are replaced following degeneration, but
epithelial thickness does not return to control levels. These findings
suggest that the number of replacement cells is not limited by the reduced
thickness of the epithelium, and that recovery mechanisms may function to
restore an optimum number of receptor cells.
相似文献
123.
The metabolism of 3-fluoro-3-deoxy-D-glucose (3-FDG) in rat brain in vivo was investigated noninvasively using 19F nuclear magnetic resonance (NMR) Spectroscopy. Following an intravenous infusion of 3-FDG, 400 mg/kg, four resonances assigned to the α and β anomers of 3-FDG, 3-fluoro-3-deoxy-D-sorbitol, and 3-fluoro-3-deoxy-D-fructose were clearly resolved in brain, a result indicating that 3-FDG is metabolized primarily into the aldose reductase sorbitol (ARS) pathway. An orally administered aldose reductase inhibitor, sorbinil, caused reduction of the flux of 3-FDG into the ARS, an observation suggesting that the method can be applied in quantitative studies of ARS path way activities. Studies of 24-h urine specimens showed that in addition to the two metabolites observed in brain, F-was excreted into the urine. 3-FDG appears to be a suitable metabolic probe for assessing glucose metabolism in the ARS pathway by in vivo 19F NMR Spectroscopy. 相似文献
124.
Tsutomu Nakada Ingrid L. Kwee Alfred M. Lerner Michael P. Remler 《The Western journal of medicine》1983,138(3):371-374
The clinical features and management of theophylline-induced seizures are not well appreciated in spite of their unique aspects. These seizures tend to occur in neurologically intact patients and leave no or only minor neurologic sequelae if controlled early. They begin with focal motor seizures with or without secondary generalization and are followed by stupor or coma. They are responsive only to adjustment of theophylline dosage. Should the motor phenomenon persist, it takes the form of epilepsia partialis continua. Extensive workup for a structural brain lesion may be unrewarding. The electroencephalogram typically shows periodic lateralized epileptiform discharges, which may provide a diagnostic clue. 相似文献
125.
126.